Bluejay Diagnostics (BJDX) Total Current Liabilities (2021 - 2026)

Bluejay Diagnostics (BJDX) has 6 years of Total Current Liabilities data on file, last reported at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 7.39% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 7.39% YoY), and the FY2025 full-year result was $1.1 million, up 38.11% from the prior year.
• Total Current Liabilities rose to $1.4 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $2.8 million in Q3 2023 to a low of $810368.0 in Q4 2024.
• A 5-year average of $1.5 million and a median of $1.4 million in 2026 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities surged 157.43% in 2022 and sank 64.29% in 2024, its largest moves.
• Tracing BJDX's Total Current Liabilities over 5 years: stood at $1.6 million in 2022, then climbed by 7.99% to $1.8 million in 2023, then sank by 54.25% to $810368.0 in 2024, then soared by 38.11% to $1.1 million in 2025, then climbed by 26.33% to $1.4 million in 2026.
• Business Quant data shows BJDX's Total Current Liabilities at $1.4 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.